Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06687837 · ClinicalTrials.gov registry record · Phase 1

Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

A Phase 1 study of Parkinson Disease, sponsored by Jeffrey S. Schweitzer, MD, PhD.

Recruiting
Registry status
Phase 1
Development phase
8
Enrollment target
1
Study location

NCT06687837 is a Phase 1 study of Parkinson Disease that is actively recruiting participants, run by Jeffrey S. Schweitzer, MD, PhD. The registered enrollment target is 8 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06687837, a Phase 1 study of Parkinson Disease, is actively recruiting participants, sponsored by Jeffrey S. Schweitzer, MD, PhD.

RECRUITING
Registry status
Phase 1
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to assess the safety and tolerability of the surgical transplantation of dopaminergic progenitor cells into the brains of participants with Parkinson's disease. The transplanted dopaminergic cells will be derived from the participant's own skin cells.

Conditions Studied

Parkinson Disease

Interventions

  • BIOLOGICAL autologous dopaminergic cell implantation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-04-29
Est. Completion 2028-12
Phase Phase 1

Sponsor

Jeffrey S. Schweitzer, MD, PhD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06687837

The ClinicalTrials.gov registry entry for NCT06687837 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Jeffrey S. Schweitzer, MD, PhD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which autologous dopaminergic cell implantation is the first listed.

NCT06687837 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06687837 about?

NCT06687837 is a clinical study titled "Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons". The goal of this clinical trial is to assess the safety and tolerability of the surgical transplantation of dopaminergic progenitor cells into the brains of participants with Parkinson's disease. The transplanted dopaminergic cells will be derived from the participant's own skin cells.

What is the current status of trial NCT06687837?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2025-04-29. Estimated completion is 2028-12.

What conditions does trial NCT06687837 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06687837?

The interventions under investigation include: autologous dopaminergic cell implantation (BIOLOGICAL).

Who is sponsoring clinical trial NCT06687837?

This trial is sponsored by Jeffrey S. Schweitzer, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06687837 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.